Repligen RGEN Total debt

Total debt at other companies

Thermo Fisher ScientificTMO

$39.18B+4.6%

DanaherDHR

$27.86B+50.1%

Maravai LifeSciences Holdings, Inc.MRVI

$270.88M-17.1%

Bio-Rad LaboratoriesBIO

$987.3M-28.4%

Charles River LaboratoriesCRL

$3.04B+8.1%

TEC

Bio-TechneTECH

$290.32M-31.4%

FAQ

What is Repligen's total debt?

Repligen (RGEN) reported total debt of $690.94M in Q2 2026.

How has Repligen's total debt changed year-over-year?

Repligen's total debt increased by 353.6% year-over-year, from $152.34M to $690.94M.

What is the long-term trend for Repligen's total debt?

Over 5 years (2020 to 2025), Repligen's total debt has grown at a 85.2% compound annual growth rate (CAGR), from $31.68M to $689.95M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.